Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Raw Materials (2024 - 2025)

Hinge Health (HNGE) has disclosed Raw Materials for 2 consecutive years, with $6.6 million as the latest value for Q4 2025.

  • Quarterly Raw Materials rose 35.71% to $6.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Dec 2025, up 35.71% year-over-year, with the annual reading at $6.6 million for FY2025, 35.71% up from the prior year.
  • Raw Materials hit $6.6 million in Q4 2025 for Hinge Health, down from $6.8 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $6.8 million in Q3 2025 to a low of $4.8 million in Q4 2024.